Taken together, these data demonstrate that CD117-sap + mATG enabled high-level engraftment of CD68-ECO-ET3-LV modified donor LT-HSCs in the absence of prolonged lymphopenia in a majority of HSCT recipients. This evidence concerns the gene KIT and lymphopenia.